Chemotherapy of hormone-resistant carcinoma of the prostate: 4-epi-rubicin weekly v.s. DMF monthly.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D004317:Doxorubicin / Q000627:therapeutic use*; D015251:Epirubicin; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D008937:Mitomycins; D015251:Epirubicin; D016685:Mitomycin; D004317:Doxorubicin; D005472:Fluorouracil